These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 21869700)

  • 1. DRD2 Taq1A polymorphism modulates prolactin secretion induced by atypical antipsychotics in healthy volunteers.
    López-Rodríguez R; Román M; Novalbos J; Pelegrina ML; Ochoa D; Abad-Santos F
    J Clin Psychopharmacol; 2011 Oct; 31(5):555-62. PubMed ID: 21869700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the Taq1A variant in the dopamine D₂ receptor gene and common CYP2D6 alleles on prolactin levels in risperidone-treated boys.
    Roke Y; van Harten PN; Franke B; Galesloot TE; Boot AM; Buitelaar JK
    Pharmacogenet Genomics; 2013 Sep; 23(9):487-93. PubMed ID: 23851570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between dopamine-related polymorphisms and plasma concentrations of prolactin during risperidone treatment in schizophrenic patients.
    Yasui-Furukori N; Saito M; Tsuchimine S; Nakagami T; Sato Y; Sugawara N; Kaneko S
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1491-5. PubMed ID: 18579277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of olanzapine, risperidone, and quetiapine on dopamine receptor types in regions of rat brain: implications for antipsychotic drug treatment.
    Tarazi FI; Zhang K; Baldessarini RJ
    J Pharmacol Exp Ther; 2001 May; 297(2):711-7. PubMed ID: 11303062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics of quetiapine in healthy volunteers: association with pharmacokinetics, pharmacodynamics, and adverse effects.
    Cabaleiro T; López-Rodríguez R; Román M; Ochoa D; Novalbos J; Borobia A; Carcas A; Abad-Santos F
    Int Clin Psychopharmacol; 2015 Mar; 30(2):82-8. PubMed ID: 25025989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The atypical antipsychotics olanzapine and quetiapine, but not haloperidol, reduce ACTH and cortisol secretion in healthy subjects.
    Cohrs S; Röher C; Jordan W; Meier A; Huether G; Wuttke W; Rüther E; Rodenbeck A
    Psychopharmacology (Berl); 2006 Mar; 185(1):11-8. PubMed ID: 16432682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP2D6 and DRD2 genes differentially impact pharmacodynamic sensitivity and time course of prolactin response to perphenazine.
    Aklillu E; Kalow W; Endrenyi L; Harper P; Miura J; Ozdemir V
    Pharmacogenet Genomics; 2007 Nov; 17(11):989-93. PubMed ID: 18075468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variants in the DRD2 locus and antipsychotic-related prolactin levels: A meta-analysis.
    Miura I; Zhang JP; Hagi K; Lencz T; Kane JM; Yabe H; Malhotra AK; Correll CU
    Psychoneuroendocrinology; 2016 Oct; 72():1-10. PubMed ID: 27333159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics.
    Tauscher J; Hussain T; Agid O; Verhoeff NP; Wilson AA; Houle S; Remington G; Zipursky RB; Kapur S
    Am J Psychiatry; 2004 Sep; 161(9):1620-5. PubMed ID: 15337652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to atypical antipsychotics in patients with schizophrenia.
    Szekeres G; Kéri S; Juhász A; Rimanóczy A; Szendi I; Czimmer C; Janka Z
    Am J Med Genet B Neuropsychiatr Genet; 2004 Jan; 124B(1):1-5. PubMed ID: 14681904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of therapy with atypical antipsychotic drugs on prolactin concentration in patients with schizophrenia and schizoaffective disorders.
    Gorobets LN
    Bull Exp Biol Med; 2005 Dec; 140(6):714-5. PubMed ID: 16848233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin response to nemonapride, a selective antagonist for D2 like dopamine receptors, in schizophrenic patients in relation to Taq1A polymorphism of DRD2 gene.
    Mihara K; Kondo T; Suzuki A; Yasui N; Nagashima U; Ono S; Otani K; Kaneko S
    Psychopharmacology (Berl); 2000 Apr; 149(3):246-50. PubMed ID: 10823405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender-specific prolactin response to antipsychotic treatments with risperidone and olanzapine and its relationship to drug concentrations in patients with acutely exacerbated schizophrenia.
    Yasui-Furukori N; Saito M; Nakagami T; Sugawara N; Sato Y; Tsuchimine S; Furukori H; Kaneko S
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):537-40. PubMed ID: 20170699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of antipsychotic drug treatment on prolactin concentrations in elderly patients.
    Kinon BJ; Stauffer VL; McGuire HC; Kaiser CJ; Dickson RA; Kennedy JS
    J Am Med Dir Assoc; 2003; 4(4):189-94. PubMed ID: 12837139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of dopamine D2 receptor gene polymorphisms with prolactin levels related to risperidone treatment: A systematic review and meta-analysis.
    Ma L; Xiang Q; Zhou S; Tan Y; Zhang X; Yang T; Xie Q; Mu G; Zhao X; Zhou Y; Li S; Cui Y
    J Clin Pharm Ther; 2019 Aug; 44(4):543-552. PubMed ID: 31056781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine effects of quetiapine in healthy volunteers.
    de Borja Gonçalves Guerra A; Castel S; Benedito-Silva AA; Calil HM
    Int J Neuropsychopharmacol; 2005 Mar; 8(1):49-57. PubMed ID: 15469666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin secretion in patients receiving clozapine, olanzapine, quetiapine and risperidone.
    Manu P; Correll CU; Wampers M; van Winkel R; Yu W; Shiffeldrim D; Kane JM; De Hert M
    Schizophr Res; 2013 Feb; 143(2-3):358-62. PubMed ID: 23231880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance].
    Besnard I; Auclair V; Callery G; Gabriel-Bordenave C; Roberge C
    Encephale; 2014 Feb; 40(1):86-94. PubMed ID: 23928066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin levels in antipsychotic treatment of patients with schizophrenia carrying the DRD2*A1 allele.
    Young RM; Lawford BR; Barnes M; Burton SC; Ritchie T; Ward WK; Noble EP
    Br J Psychiatry; 2004 Aug; 185():147-51. PubMed ID: 15286066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical antipsychotics and dopamine D(1) receptor agonism: an in vivo experimental study using core temperature measurements in the rat.
    Oerther S; Ahlenius S
    J Pharmacol Exp Ther; 2000 Feb; 292(2):731-6. PubMed ID: 10640312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.